Abstract:Objective To evaluate the therapeutic effect and possible mechanism of intrapleural administra- tion of cisplatin bound to activated carbon particles for treating malignant pleura] effusions(MPE). Methods ①60 patients with MPE confirmed in the Third Hospital of Changzhou and the Second Hospital of Changzhou from 2004 to 2007 were randomly divided into treatment group (n=30)and control group(n=30). Chest catheters were inserted percutaneously into the pleural space to drain the effusions. Cisplatin mixed with activated carbon particles for the treatment group and only cisplatin for the control group were injected into pleural cavity. Whether above-mentioned treatment should be repeated was determined by ultrasonic B every week until up to four times. Curative effect and side-effect were compared between two groups a month later. ②20 cases, randomly selected from both groups respectively, underwent whole body and chest SPECT scan to image lymphatic system by means of 99Tcm-DX after effusions drainage but before intrapleural injection of drug. Cases whose imaging graphics were abnormal would undergo the above SPECT again 2 weeks after intrapleural injection of drug so as to find changes in imaging graphics. Results ① The overall response rate was significantly higher in treatment group than in control group(100% (30/30) vs 66.7% (20/30), χ2=12.00, P<0.01)and that intrapleural injection was needed only once in most cases. Gastrointestinal upset and leucoponia were less and milder in treatment group than in control group (16.7% (5/30) vs 30.0% (9/30) and 6.7% (2/30) vs 20.0% (6/30) respectively),but there was no statistical difference between the two groups(χ2=1.49 and 1.30,P>0.05). ②The rate of improvement in lymphatic imaging was significantly higher in treatment group than in control group (78.6% (11/14) vs 37.5% (6/16),P<0.05). Conclusion The treatment of malignant pleural effusions with intrapleural administration of cisplatin bound to activated carbon particles is extremely effective and safe, and can improve lymphatic drainage as well.

Clinical effect of highly agglutinative staphylococcin combined with cisplatin in treatment of malignant pleural effusion

Clinical effect of highly agglutinative staphylococcin and lentinan combined with cisplatin in treatment of malignant pleural effusion caused by lung cancer

Tunnelled pleural catheter insertions and intrapleural administration of drugs for malignant pleural effusion: a clinical control study

Intracavitary infusion treatment of malignant effusion in body cavity with highly agglutinated staphytococcin plus cisplatin

Therapeutic Effect and Mechanism of Intrapleural Administration of Cisplatin Bound to Activated Carbon Particles for Treating Malignant Pleural Effusion

Analysis of Differences of Fever Caused by Cisplatin Combined with Staphylococcin or Lentinan in Malignant Pleural Effusion

Clinical Observation on Intrapleural Administration of Cisplatin and IL-2 Combined with Systemic Chemotherapy in the Treatment of Malignant Pleural Effusion of Lung Cancer

Intrapleural Chemo- and Hyperthermotherapies for Malignant Pleural Effusion: A Randomized Prospective Study

Clinical Efficacy of Cisplatin Plus Compound Kushen Injection and IL-2 for Malignant Pleural Effusion in Elder Patients

Intrapleural Administration of Cisplatin to Treat Malignant Pleural Effusions in Patients with Non-Small Cell Lung Cancer:The Efficacy and Pharmacokinetics

Effect of intrapleural perfusion chemotherapy on malignant pleural effusion in patients with non-small cell lung cancer

Efficacy Study of Hyperthermotherapy Combined with Cisplatin Injected into Thoracic Cavity in the Treatment of Pleural Effusion from Malignant Neoplams

Hyperthermia combined with intracavitary injection of drug for malignant pleural effusion

Intrapleural Combination Bevacizumab with Cisplatin Therapy for Non-Small Cell Lung Cancer Caused by Non-Small Cell Lung Cancer

Therapeutic Observation of Endostar Combined with Cisdiammi Dichloride Platinum on Non-Small Cell Lung Cancer with Malignant Pleural Effusion

Effect of the combination of recombinant human endostatin injection and intrapleural hyperthermic perfusion with nadaplatin on treatment efficacy of non-small cell lung cancer complicated with pleural effusion

Clinical observation of pleural hyperthermic perfusion chemotherapy with Endostar and Lobaplatin for treatment of malignant pleural effusion

Improved Percutaneous Placement Catheters Drainage of Thoracocentesis Accompanying with Intracavitary Chemotherapy for the Treatment of Malignant Pleural Effusion

Better Efficacy of Intrapleural Infusion of Bevacizumab with Pemetrexed for Malignant Pleural Effusion Mediated from Nonsquamous Non-Small Cell Lung Cancer

Short-Term and Long-Term Efficacy of Endostar Combined with Cis-Diaminedichloroplatinum in Treating Malignant Pleural Effusion of Non-Small Cell Lung Cancer